Topics
Glioblastoma | Treatment | Targeted therapy | BRAF-MEK-inhibitors
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > BRAF-MEK-inhibitors
Steininger J, Buszello C, Oertel R, Meinhardt M, Schmid S,
Engellandt K, Herold S, Stasik S, Ebrahimi A, Renner B, Thiede C,
Eyüpoglu IY, Schackert G, Beissert S, Meier F, Radke J,
Westphal D, Juratli TA.
Efficacy of
BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a
novel BRAFV600 mutation.
Acta
Neuropathol Commun. 2024 Aug 6;12(1):124. doi:
10.1186/s40478-024-01834-8. PMID:
39107839. Case report. ˍ
Homma T, Suzuki T, Kato T, Shirahata M, Mishima K.
Cerebrospinal
fluid cytology in a case of epithelioid glioblastoma.
Cytopathology.
2024 Aug 13. doi:
10.1111/cyt.13436. PMID:
39136219. Case report. ˍ